Real-time enrollment status for this hematopoietic and lymphoid system neoplasm clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 11:25 AM UTC
| NCT Number | NCT06314672 |
| Recruiting Status | Recruiting |
| Condition | Hematopoietic and Lymphoid System Neoplasm |
| Phase | NA |
| Target Enrollment | 208 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Ohio State University Comprehensive Cancer Center |
| Last Updated on CT.gov | June 9, 2026 (Jun 9, 2026) |
As of July 19, 2026: Clinical trial NCT06314672 is currently recruiting participants. This na study for hematopoietic and lymphoid system neoplasm is actively seeking new participants at 1 location across the United States. The study is sponsored by Ohio State University Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06314672 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06314672 was last updated Jun 9, 2026 (June 9, 2026). HelloStudys verifies this status automatically.